- Filed
- Mar 18, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Jan 31, 2026 | 37.93M sh |
| Shares Diluted restated | Q1 2026 · Jan 31, 2025 | 38.5M sh |
| Shares Outstanding | Q1 2026 · Jan 31, 2026 | 38.5M sh |
| Capex | Q1 2026 · Jan 31, 2026 | $71.6K |
| Operating Cash Flow | Q1 2026 · Jan 31, 2026 | $227.06K |
| Operating Cash Flow | Q1 2026 · Jan 31, 2025 | −$162.16K |
| Cash And Equivalents | Q1 2026 · Jan 31, 2026 | $721.37K |
| Cash And Equivalents | Q1 2026 · Oct 31, 2025 | $605.05K |
| Stockholders Equity | Q1 2026 · Jan 31, 2026 | $2.22M |
| Stockholders Equity | Q1 2026 · Oct 31, 2025 | $2.06M |
| Stockholders Equity restated | Q1 2026 · Jan 31, 2025 | $1.56M |
| Stockholders Equity | Q1 2026 · Oct 31, 2024 | $1.44M |
| Current Liabilities | Q1 2026 · Jan 31, 2026 | $226.22K |
| Current Liabilities | Q1 2026 · Oct 31, 2025 | $129.54K |
| Total Liabilities | Q1 2026 · Jan 31, 2026 | $249.12K |
| Total Liabilities | Q1 2026 · Oct 31, 2025 | $152.44K |
| Current Assets | Q1 2026 · Jan 31, 2026 | $1.67M |
| Current Assets | Q1 2026 · Oct 31, 2025 | $1.52M |
| Total Assets | Q1 2026 · Jan 31, 2026 | $2.47M |
| Total Assets | Q1 2026 · Oct 31, 2025 | $2.21M |
| Eps Diluted | Q1 2026 · Jan 31, 2026 | $0.00 |
| Eps Diluted | Q1 2026 · Jan 31, 2025 | $0.00 |
| Eps Basic | Q1 2026 · Jan 31, 2026 | $0.00 |
| Eps Basic | Q1 2026 · Jan 31, 2025 | $0.00 |
| Sga Expense | Q1 2026 · Jan 31, 2026 | $216.56K |
| Sga Expense | Q1 2026 · Jan 31, 2025 | $272.1K |
| Net Income | Q1 2026 · Jan 31, 2026 | $161.64K |
| Net Income | Q1 2026 · Jan 31, 2025 | $36.2K |
| Operating Income | Q1 2026 · Jan 31, 2026 | $168.08K |
| Operating Income | Q1 2026 · Jan 31, 2025 | $40.79K |
| Revenue | Q1 2026 · Jan 31, 2026 | $632.2K |
| Revenue | Q1 2026 · Jan 31, 2025 | $543.92K |